An interventional study of Affect labeling in Emotional Dysregulation, sponsored by Karolinska Institutet. Completed at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-09.
Sponsored by Karolinska Institutet · Not applicable, Interventional, and Basic science
The overall aim of this project is to better understand the emotion regulating effect of labeling emotions (affecting labeling, AL) for individuals with self-perceived emotional regulation difficulties from both a clinical population and a non-clinical population, by using both self-assessment and psychophysiological testing of emotional activation. The main part of the project includes a brief intervention aiming to test the emotion-regulating effect of a short behavioral intervention to learn and practice AL. This two-week intervention, aims to improve the ability to regulate emotions, and to assess the benefits of emotion regulation strategies for individuals with and without a clinical diagnosis, but with self-perceived difficulties in emotion regulation.
The second part of this study aims to conceptually replicate a previous basic research study on AL and its emotion-regulating effect in a experimental laboratory setting and to extend that replication to include a clinical group. The replication contributes to an indepth understanding of AL as an implicit emotion regulation strategy in the short term, i.e. as a strategy used directly in the emotionally charged situation, and expands that knowledge to also include the effect in individuals with a clinical diagnosis. Also, it provides the opportunity to evaluate the effect of the two week AL behavioral intervention using psychophysiological testing.
Main study: AFFECT LABELING - DAILY EXERCISE IN PUTTING WORDS ON EMOTIONS DESIGN AND PROCEDURE This clinical study is a randomized, wait-list controlled design with repeated measurements. Participants are randomized at inclusion between being directly offered a 14-day course to train AL and waiting two weeks before beginning the intervention. Participants are blind to this randomization and do not know that they are in the waitlist condition, in order to avoid nocebo effects. The randomization is done 1: 1, and stratified by clinical categorization (participants with or without a psychiatric diagnosis).
The course is given via a secure web platform (BASS4) in which the participant also makes all their assessments, and interacts with the study material and their course leader (clinical psychologist or master level psychology students).
Intervention - web course in affect labeling The intervention is given as a two week internet-delivered course in using AL with the guidance of a course leader (licensed psychologist or psychologist assistant under supervision). The course is divided into two modules where module 1 contains a) Psychoeducation about different emotions and its function, b) Information about AL and its potential emotion-regulating effect, c) Instruction on how to use AL in everyday life and d) Planning of daily short exercises in naming emotions. Daily registration with multiple choice answers is introduced to help the practice of AL. All assessments are web-based and reminders are sent to the participants' cellphone. The course leader is active in providing feedback on the exercises and planning.
Module 2 is largely a continuation of module 1 where any obstacles and other difficulties are discussed in order to increase the chance of active practice in AL, and continued daily practice. Module 3 is a brief summary of what has been taught and is made available to the participant after post-assessment.
Laboratory sub-study: Participants will also participate in a laboratory-based study where the emotion regulating effect of AL will be compared with distraction or passive viewing while being exposed to emotionally provocative visual stimuli. Participants are exposed to 3 blocks of 8 images and questions about the images ("trials") with equal numbers of negative and neutral valence in three conditions: instruction to "Watch", instruction to use AL and instruction to use Distraction. The instructions and pictures are given in a randomized, balanced order. Before each block, a 3-second instruction is displayed that indicates whether the participant should use "Watch", "AL" or "Distraction" for all 8 images in the block.
All participants will carry out the laboratory sub-study on two occasions: before and after the 14 day period it takes for the individuals who directly receives the web-based course in AL to complete it.
Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
To be part of the clinical group, the participant must state a diagnosis established by a medical professional in the last 5 years, which involves clinical difficulties with emotion regulation such as binge eating disorder, emotional instability, generalized anxiety, depression, social anxiety or ADHD, and does not plan to start, change or discontinue any psychosocial or pharmacological treatment within the next 4 weeks. The non-clinical group must not have been diagnosed or treated for mental illness in the last 5 years.
Randomized to immediate two-week, internet delivered psychoeducative course in affect labeling
Behavioral: Affect labeling
Randomized to a two-week wait-list control
Short behavioral intervention teaching affect labeling
Change in The Difficulties in Emotion Regulation Scale, DERS (Gratz & Roemer, 2004)
Min 36, Max 180. Higher scores represents worse outcome
Time frame: At day 1 and at day 14 (+/- 5 days)
The Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001)
Min 0, Max 27. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
The Generalized Anxiety Disorder 7-item Scale (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006).
Min 0, Max 21. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
The Emotion Regulation Questionnaire (ERQ; Gross & John, 2003)
Two sub scales: Cognitive reappraisal: Min 6 Max 42. Higher scores represents higher use of reappraisal. Suppression: Min 4 Max 28. Higher scores represents more use of suppression.
Time frame: At day 1 and day 14 (+/- 5 days)
The Toronto Alexithymia Scale (TAS-20; Bagby et al., 1994).
Min 20, Max 100. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
The Ruminative responses scale - Brooding and Reflection (RRS-BR; Treynor et al., 2003, Cronwall, 2019).
Min 10 Max 40. Higher scores represents worse outcome
Time frame: At baseline and day 14 (+/- 5 days)
the Client Satisfaction Questionnaire, 8 item (CSQ-8; Attkisson & Zwick, 1982).
Min 8 Max 32 Higher scores represents better outcome
Time frame: At day 14 (+/- 5 days)
Levels of expected emotional upset
9-degree Likert scale. Min 1 (Not upset at all) Max 9 (Very upset).
Time frame: At day 1 and day 14 (+/- 5 days)
Change in skin conductance response between three different emotion regulation conditions
changes in skin conductance, mean (micro-Siemens (μS)) between the different emotion regulation conditions
Time frame: 3*8*5 seconds at Day 1 and at Day 14 (+/-5 days)
Change in Heart Rate Variability (HRV) (micro-Siemens (μS)) averaged over a 5 sec time window, and repeated 8 times per condition, ie. 8*5 seconds repeated 3 times.
Heart Rate Variability is a measure which indicates the variation in your heartbeats within a specific timeframe.
Time frame: At day 1 and at day 14 (+/- 5 days)
Change in The Affect Labeling Questionnaire, ALQ (Sahi, et al. (in prep)
Min 12, Max 60. Higher scores represents better outcome
Time frame: At day 1 and at day 14 (+/- 5 days)
Change in Experienced emotional upset (Time frame: averaged over a 5 sec time window, repeated 24 times during the experiment)
9-degree Likert scale. Min 1 (Not upset at all) Max 9 (Very upset).
Time frame: At day 1 and day 14 (+/- 5 days)
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska Institutet